- $9.11bn
- $10.10bn
- $2.55bn
Annual income statement for Legence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 1,247 | 1,615 | 2,099 | 2,550 |
| Cost of Revenue | ||||
| Gross Profit | 234 | 315 | 431 | 536 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 1,271 | 1,605 | 2,028 | 2,496 |
| Operating Profit | -24.2 | 10.3 | 70.4 | 54.9 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -74.7 | -53.9 | -23.1 | -55.1 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -82.3 | -46 | -27.6 | -77.3 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -82.3 | -46 | -28.6 | -59.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -82.3 | -46 | -28.6 | -59.8 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.569 | -0.267 | -0.023 | -0.335 |